Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexamethasone on [11C]temozolomide biodistribution in glioblastoma
NL-OMON29066Recruiting
- Sponsor
- VU University Medical Center
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone and temozolomide in glioblastoma (GBM), sponsored by VU University Medical Center. Primary endpoint: Effect of dexamethasone on [11C]temozolomide biodistribution. Started Oct 2012; status: recruiting.
02
Drugs
dexamethasonetemozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NL-OMON29066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29066.